Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats

L. R. McMahon, Paul J. Wellman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The anorexic effects of phenylpropanolamine (PPA) have been attributed to activation by PPA of α1-adrenoceptors within rat hypothalamic paraventricular nucleus (PVN). The PVN, however, is a nexus for a number of ascending and descending fibers systems that release transmitters and modulators known to inhibit appetite. The focus of the present study was to assess the possibility that oxytocin activity might play a role in the anorexic action of PPA. The present study therefore examined the effects of systemic administration of the oxytocin antagonist L-366,948 on PPA-induced anorexia. Adult male rats (n = 10 per group) were pretreated (IP) with either 0, 1, or 2 mg/kg L-366,948 15 min prior to treatment injections (IP) of either 0, 5, 10 and 15 mg/kg PPA. Food and water intakes were recorded for a 30 min period (1600 h) starting 30 min after the treatment injection. Rats pretreated with vehicle and then treated with PPA exhibited a dose-dependent suppression of feeding with a maximal effect evident at 15 mg/kg PPA. Pretreatment with 1 or 2 mg/kg L-366,948 alone did not alter feeding nor did these doses alter the anorexia induced by PPA. These results suggest that direct or indirect oxytocin activity is not a factor in the anorexic action of PPA, a finding that further strengthens the notion that PPA inhibits food intake via activation of α1-adrenoceptors.

Original languageEnglish (US)
Pages (from-to)767-770
Number of pages4
JournalPharmacology Biochemistry and Behavior
Volume57
Issue number4
DOIs
StatePublished - Aug 1997
Externally publishedYes

Fingerprint

Phenylpropanolamine
Oxytocin Receptors
Anorexia
Rats
L 366948
Oxytocin
Paraventricular Hypothalamic Nucleus
Adrenergic Receptors
Eating
Chemical activation
Injections
Appetite
Modulators
Drinking
Transmitters

Keywords

  • α1-Adrenergic receptors
  • Feeding
  • L-366,948

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats. / McMahon, L. R.; Wellman, Paul J.

In: Pharmacology Biochemistry and Behavior, Vol. 57, No. 4, 08.1997, p. 767-770.

Research output: Contribution to journalArticle

@article{b5d1fdfcbc5f4c1590c7c2ef6ee63f4d,
title = "Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats",
abstract = "The anorexic effects of phenylpropanolamine (PPA) have been attributed to activation by PPA of α1-adrenoceptors within rat hypothalamic paraventricular nucleus (PVN). The PVN, however, is a nexus for a number of ascending and descending fibers systems that release transmitters and modulators known to inhibit appetite. The focus of the present study was to assess the possibility that oxytocin activity might play a role in the anorexic action of PPA. The present study therefore examined the effects of systemic administration of the oxytocin antagonist L-366,948 on PPA-induced anorexia. Adult male rats (n = 10 per group) were pretreated (IP) with either 0, 1, or 2 mg/kg L-366,948 15 min prior to treatment injections (IP) of either 0, 5, 10 and 15 mg/kg PPA. Food and water intakes were recorded for a 30 min period (1600 h) starting 30 min after the treatment injection. Rats pretreated with vehicle and then treated with PPA exhibited a dose-dependent suppression of feeding with a maximal effect evident at 15 mg/kg PPA. Pretreatment with 1 or 2 mg/kg L-366,948 alone did not alter feeding nor did these doses alter the anorexia induced by PPA. These results suggest that direct or indirect oxytocin activity is not a factor in the anorexic action of PPA, a finding that further strengthens the notion that PPA inhibits food intake via activation of α1-adrenoceptors.",
keywords = "α1-Adrenergic receptors, Feeding, L-366,948",
author = "McMahon, {L. R.} and Wellman, {Paul J.}",
year = "1997",
month = "8",
doi = "10.1016/S0091-3057(96)00381-4",
language = "English (US)",
volume = "57",
pages = "767--770",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats

AU - McMahon, L. R.

AU - Wellman, Paul J.

PY - 1997/8

Y1 - 1997/8

N2 - The anorexic effects of phenylpropanolamine (PPA) have been attributed to activation by PPA of α1-adrenoceptors within rat hypothalamic paraventricular nucleus (PVN). The PVN, however, is a nexus for a number of ascending and descending fibers systems that release transmitters and modulators known to inhibit appetite. The focus of the present study was to assess the possibility that oxytocin activity might play a role in the anorexic action of PPA. The present study therefore examined the effects of systemic administration of the oxytocin antagonist L-366,948 on PPA-induced anorexia. Adult male rats (n = 10 per group) were pretreated (IP) with either 0, 1, or 2 mg/kg L-366,948 15 min prior to treatment injections (IP) of either 0, 5, 10 and 15 mg/kg PPA. Food and water intakes were recorded for a 30 min period (1600 h) starting 30 min after the treatment injection. Rats pretreated with vehicle and then treated with PPA exhibited a dose-dependent suppression of feeding with a maximal effect evident at 15 mg/kg PPA. Pretreatment with 1 or 2 mg/kg L-366,948 alone did not alter feeding nor did these doses alter the anorexia induced by PPA. These results suggest that direct or indirect oxytocin activity is not a factor in the anorexic action of PPA, a finding that further strengthens the notion that PPA inhibits food intake via activation of α1-adrenoceptors.

AB - The anorexic effects of phenylpropanolamine (PPA) have been attributed to activation by PPA of α1-adrenoceptors within rat hypothalamic paraventricular nucleus (PVN). The PVN, however, is a nexus for a number of ascending and descending fibers systems that release transmitters and modulators known to inhibit appetite. The focus of the present study was to assess the possibility that oxytocin activity might play a role in the anorexic action of PPA. The present study therefore examined the effects of systemic administration of the oxytocin antagonist L-366,948 on PPA-induced anorexia. Adult male rats (n = 10 per group) were pretreated (IP) with either 0, 1, or 2 mg/kg L-366,948 15 min prior to treatment injections (IP) of either 0, 5, 10 and 15 mg/kg PPA. Food and water intakes were recorded for a 30 min period (1600 h) starting 30 min after the treatment injection. Rats pretreated with vehicle and then treated with PPA exhibited a dose-dependent suppression of feeding with a maximal effect evident at 15 mg/kg PPA. Pretreatment with 1 or 2 mg/kg L-366,948 alone did not alter feeding nor did these doses alter the anorexia induced by PPA. These results suggest that direct or indirect oxytocin activity is not a factor in the anorexic action of PPA, a finding that further strengthens the notion that PPA inhibits food intake via activation of α1-adrenoceptors.

KW - α1-Adrenergic receptors

KW - Feeding

KW - L-366,948

UR - http://www.scopus.com/inward/record.url?scp=0030763698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030763698&partnerID=8YFLogxK

U2 - 10.1016/S0091-3057(96)00381-4

DO - 10.1016/S0091-3057(96)00381-4

M3 - Article

C2 - 9259004

AN - SCOPUS:0030763698

VL - 57

SP - 767

EP - 770

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 4

ER -